MENU
ZTS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ZOETIS (ZTS) DIvidends Date & History

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

A.I.Advisor
published Dividends

ZTS is expected to pay dividends on September 01, 2026

ZOETIS ZTS Stock Dividends
A dividend of $0.53 per share will be paid with a record date of September 01, 2026, and an ex-dividend date of July 20, 2026. The last dividend of $0.53 was paid on June 02. Read more...
A.I.Advisor
Jul 27, 2026

Zoetis Inc. (ZTS) Dividend Analysis: Reliable Growth in Animal Health

Key Takeaways

  • Zoetis Inc. (ZTS) offers a current dividend yield of approximately 2.81% with an annualized payout of $2.12 per share.
  • The company pays dividends quarterly at $0.53 per share, supported by a conservative payout ratio of around 33-34%.
  • Zoetis Inc. (ZTS) has delivered 15 consecutive years of dividend increases, with average annual growth of about 20% over the past decade.
  • Strong earnings and free cash flow coverage indicate sustainable dividend payments for the foreseeable future.
  • The dividend yield exceeds the healthcare sector average, positioning Zoetis Inc. (ZTS) as an appealing option for dividend growth investors.

Dividend Overview

Zoetis Inc. (ZTS) maintains a quarterly dividend policy with payments of $0.53 per share, resulting in an annualized total of $2.12. The current yield stands near 2.81%, reflecting a modest but growing income stream. As a dividend growth stock rather than a high-yield name, Zoetis Inc. (ZTS) prioritizes consistent increases alongside business expansion in the animal health sector. The most recent ex-dividend date was July 20, 2026, with the payment scheduled for September 1, 2026.

Dividend History and Growth

Zoetis Inc. (ZTS) has built a strong record of dividend growth since initiating payouts. The company has raised its dividend for 15 consecutive years, achieving an average annual increase of roughly 20% over the past 10 years. Quarterly payments have risen steadily, with recent hikes reflecting robust underlying performance. This consistency underscores a long-term strategy focused on returning capital to shareholders while funding innovation and acquisitions.

Dividend Sustainability and Payout Ratio

The dividend appears well-supported by financial metrics. Zoetis Inc. (ZTS) maintains a payout ratio of approximately 33-34%, well below typical thresholds for sustainability. Earnings coverage remains strong, and free cash flow provides additional buffer against economic fluctuations. Low debt levels relative to peers and steady cash generation from core operations further enhance the outlook for ongoing payments without strain on the balance sheet.

Dividend Compared to Industry Peers

Zoetis Inc. (ZTS) delivers a higher yield than the broader healthcare sector average of about 1.58%. Within animal health and pharmaceuticals, the company's combination of yield and growth rate stands out favorably against many competitors that offer lower yields or shorter dividend histories. This profile appeals to investors seeking above-average income with growth potential in a defensive industry.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

Zoetis Inc. (ZTS) suits dividend growth investors seeking moderate yields with a proven history of annual increases and strong coverage ratios. Long-term investors focused on compounding returns may find the combination of quarterly payments, low payout ratio, and sector stability appealing. Income-oriented investors preferring higher yields might look elsewhere, while conservative portfolios could value the defensive nature of the animal health business. The stock offers a balanced profile for those prioritizing sustainability over immediate high income.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com